ライフサイエンスコーパス: dialysate

1 vior and the K(+)-evoked increase in GABA in dialysate.

2 tenuates the K(+)-evoked increase of GABA in dialysate.

3 be increased by addition of a sorbent to the dialysate.

4 -methoxytyramine concentrations in rat brain dialysate.

5 ut at the cost of some albumin loss into the dialysate.

6 water (HDO) between blood/body water and the dialysate.

7 s was used to analyze the composition of the dialysate.

8 ction of Ado was also observed in the kidney dialysate.

9 everal unknown peptides that were present in dialysate.

10 0 microM) to increase DA, NE and 5-HT in the dialysate.

11 ord some protection against endotoxin in the dialysate.

12 (changing of temperature) modulation of the dialysate.

13 gastric dialysate and 9.17units/mL intestine dialysate.

14 sociates with the release of IL-1beta in the dialysate.

15 losed to circulate the therapeutic enzyme in dialysate.

16 then performed with a novel low bicarbonate dialysate.

17 and TNRNFLRFa were sequenced from hemolymph dialysates.

18 oxytyramine, and serotonin concentrations in dialysates.

19 Glutamate is significantly elevated in these dialysates.

20 measure smaller amounts of substances in the dialysates.

21 and asparate were readily detectable in EPN dialysates.

22 erved in glutamate levels of arcuate nucleus dialysates.

23 to a significant dose-dependent increase in dialysate (0.3 mg kg(-1): 999+/-287%; 0.5 mg kg(-1): 132

24 C, compared with treatments with the cooler dialysate (1.49 +/- 1.12 vs 0.72 +/- 0.69; incidence rat

25 in which patients received either low-sodium dialysate (135 mM) or conventional dialysate (140 mM) fo

26 ow-sodium dialysate (135 mM) or conventional dialysate (140 mM) for 12 months.

27 ll nicotine exposure paradigms increased VTA dialysate 2-arachidonoyl glycerol (2-AG) levels.

28 d into the MH via a microdialysis probe, and dialysate 5-HT concentrations were measured at 20 min in

29 contained a sample introduction channel for dialysate, a precolumn reactor for derivatization with o

30 detection in protein-free ultrafiltrates or dialysates, a highly sensitive amplification assay was d

31 avenous dipyridamole enhanced resting muscle dialysate adenosine (from 77+/-25 to 147+/-50 nmol/L), a

32 s, respectively, but did not increase muscle dialysate adenosine concentration (from 88+/-21 to 65+/-

33 diabetic rats but SP-LI levels in spinal CSF dialysates after paw formalin injection were significant

34 le-body amino acid turnover studies identify dialysate amino acid loss and reduced protein synthesis

35 ynthesis may be a compensatory adaptation to dialysate amino acid loss with a consequent reduction in

36 heat bread was found as 5.91units/mL gastric dialysate and 9.17units/mL intestine dialysate.

37 ddition, the use of biocompatible peritoneal dialysate and administration of growth hormone independe

38 ulation with calcium-free citrate-containing dialysate and calcium reinjection according to ionic dia

39 oncern has arisen regarding high-bicarbonate dialysate and dialysis-induced alkalemia, but whether th

40 ed, even across species, with plasma-derived dialysate and involves nitric oxide, stromal derived fac

41 epend on the ratio of their concentration in dialysate and plasma (D/P) and the drain volume (Dv) cor

42 Dialysate and plasma cytokines were measured by electroc

43 een peptidoglycan concentrations in recalled dialysate and reports of aseptic peritonitis.

44 lar weight cutoff dialysis membrane, and the dialysate and retentate were analyzed by UV-visible abso

45 During the test session, dialysate and video recording samples were collected fro

46 ining two substrates were collected into the dialysate and were subsequently analyzed off-line using

47 =212) or the 1.75-mmol/L Ca (1.75 Ca; n=213) dialysate arm.

48 iovascular response to HDF or HD with cooled dialysate as assessed with intradialytic MRI.

49 allow enzyme assay reagents to be mixed with dialysate as sample plugs formed.

50 95% CI=0.25 to 0.94, P=0.03), and ultrapure dialysate associated with a lower risk for cardiovascula

51 The times for dialysate at the exit of the bare and hydrogel-coated mi

52 MK-591 reduced LTB4 concentrations in rectal dialysate at the final determination.

53 Successive monitoring of striatal dialysates at a temporal resolution of 7.7 min showed th

54 cess infection, less-than-sterile dialysate, dialysate back leak, and nonbiocompatible membranes in a

55 The dialysate monitor eliminated errors from dialysate bacterial contamination, simplified dialysate

56 a widely varying membrane type, and standard dialysate blood lines.

57 tly increased glutamate release into the CeA dialysate but only after CET.

58 the magnitude of the increase in dopamine in dialysate, but other factors are also involved.

59 ange dopamine concentrations in rat striatal dialysates, but increased those of serotonin by 182% (ac

60 nly used to measure target substances in the dialysates, but other methods such as radioimmunoassay m

61 s were due to peptidoglycan contamination of dialysate by Alicyclobacillus.

62 lculated by dividing the amount recovered in dialysate by the serum area under the curve during hemod

63 antly raised levels of GABA in the recovered dialysates by approximately 40%.

64 udy, we investigated the effects of lowering dialysate Ca level on progression of CAC and histologic

65 Thus, lowering dialysate Ca levels slowed the progression of CAC and im

66 We found a 62% increase in the dialysate [Ca2+] (0.223+/-0.018 to 0.353+/-0.028 mmol/L)

67 Dialysate can be analyzed every 12.5 s using the online

68 ypes, i.e., continuous ambulatory peritoneal dialysate (CAPD), peritoneal, amniotic, pericardial, syn

69 efficiency ratio (net UF volume per gram of dialysate carbohydrate absorbed) were determined at base

70 entration was associated with an increase in dialysate cGMP concentration in both the weal and flare

71 e extracorporeal blood circuit but a minimal dialysate circuit closed to circulate the therapeutic en

72 (28%; P < 0.011), CML-apoB (25%; P < 0.028), dialysate CML (39%; P < 0.03), and dialysate MG output (

73 ; P < 0.011), CML-apoB (67%; P < 0.028), and dialysate CML output (27%; P < 0.01).

74 D-Serine was detected in dialysate collected from the rat striatum using an onlin

75 The basal dopamine concentration in dialysates collected from the striatum of anesthetized r

76 termination of vasopressin and bradykinin in dialysates collected with 5-min sampling frequency from

77 d to establish thresholds immediately before dialysate collection as well as during each sample colle

78 bicarbonate dialysate was circulated in the dialysate compartment.

79 During contraction the dialysate concentration increased 154 % above resting co

80 nline, high-speed CE allowing changes in the dialysate concentration of small molecule amine neuroche

81 antitative microdialysis was used to measure dialysate concentration, extracellular concentration and

82 A model was developed to examine serum and dialysate concentrations after intermittent intraperiton

83 toneal cefazolin provides adequate serum and dialysate concentrations for 24 h.

84 Dialysate concentrations obtained for the AOHLs and AHLs

85 The effluent dialysate concentrations of AngI and AngII were measured

86 inserted in the skeletal muscle of rats, and dialysate concentrations of ATP and NE were determined b

87 e n. accumbens of saline-treated rats, basal dialysate concentrations of DA were similar in pups and

88 ure cooled rapidly to near room temperature, dialysate concentrations of glutamate were not increased

89 Dialysate concentrations of glutamate, lactate, and pyru

90 Mean serum and dialysate concentrations were above minimum inhibitory c

91 Dialysate concentrations were below 10 pM for these pept

92 hyroid hormone levels </=300 pg/ml receiving dialysate containing 1.75 or 1.50 mmol/L Ca (n=425) were

93 Dialysates containing high salt concentrations (>150 mM)

94 esented a fourfold increase in baseline GABA dialysate content compared with naive rats.

95 Dialysate cooling ameliorated this decline but this effe

96 Dialysate cooling and sodium modelling may prevent haemo

97 study is needed to explore the potential of dialysate cooling as a therapeutic approach to slow RRF

98 Previous research shows that dialysate cooling reduces hemodialysis-induced circulato

99 Dialysate cooling resulted in a reduction in mean body t

100 perfusion, and if it can be ameliorated with dialysate cooling to potentially reduce RRF loss, is unk

101 D is unclear, VEGF concentrations in drained dialysate correlate with IL-6 levels, suggesting a link

102 al hemodialysis, addition of sorbents to the dialysate could increase the clearance of protein-bound

103 ure and further examine if the use of cooled dialysate could provide protection against hemodialysis-

104 tis count (R = 0.16; 95% CI, 0.03-0.29), and dialysate cytokines.

105 lowing amphetamine are related to changes in dialysate DA concentration as measured with microdialysi

106 dy clearly demonstrate that the magnitude of dialysate DA release is correlated with the magnitude of

107 4 g/dl was dialyzed with a standard clinical dialysate delivery system.

108 vascular access infection, less-than-sterile dialysate, dialysate back leak, and nonbiocompatible mem

109 Mass spectra of in vivo dialysates displayed neuropeptides from 10 peptide famil

110 onists) with cocaine prevents alterations in dialysate dopamine (DA) concentration in the nucleus acc

111 ous measures of the effects of naltrexone on dialysate dopamine levels in the NAcc and on operant res

112 ecreased the amphetamine-induced increase in dialysate dopamine levels in the striatum.

113 A transient rise in dialysate dopamine levels was observed during the waitin

114 ttenuated the efficacy of ethanol to elevate dialysate dopamine levels.

115 n and prevented ethanol-induced increases in dialysate dopamine levels.

116 Although the use of cooled dialysate during hemodialysis is associated with stabili

117 ndothelial growth factor-C (VEGF-C) in human dialysate effluents, peritoneal tissues, and peritoneal

118 Our modeling showed that dialysate electrolyte composition, plasma albumin, and p

119 ittent renal replacement therapy with cooler dialysate experienced significantly less hypotension dur

120 e plasma flow set at 46 +/- 3 ml/min and the dialysate flow (Q(d)) set at 42 +/- 3 ml/min using a hol

121 blood flow was 58.6 (SD 11.7) mL/min, with a dialysate flow of 47.1 (7.8) mL/min.

122 mass transfer area coefficient (KoA) and the dialysate flow rate (Qd).

123 dialyzer; median blood flow rate 400 ml/min; dialysate flow rate 600 ml/min; median hemodialysis time

124 ration profiles for PBUTs and the effects of dialysate flow rate and dialyzer size on PBUT removal.

125 odel simulations suggest that an increase in dialysate flow rate improves the reduction ratio (and re

126 , duration (T: min per treatment), and blood/dialysate flow rates (QB/QD: ml/min) on steady-state con

127 min to 100 mL/min depending on the blood and dialysate flow rates and the type of filter used.

128 rylonitrile filter at combined ultrafiltrate/dialysate flow rates of up to 3 L/hr.

129 The blood and dialysate flow rates, duration of dialysis, type of filt

130 of the level of creatinine in the patient's dialysate fluid in the course of dialysis session.

131 We validate the platform with a brain dialysate fluid sample and demonstrate reading by compar

132 ium balance and factors modulating potassium dialysate fluxes in dialysis, and we review data linking

133 In control rats, SP-LI increased in spinal dialysates following formalin injection and levels were

134 nd was dialyzed against 5 L of acetate-based dialysate for 180 min.

135 ia extracorporeal delivery was active in the dialysate for periods much longer than that in vivo thro

136 zed male rats was used to collect 3.6 microL dialysate fractions that were injected on-line into the

137 Online monitoring of serotonin in striatal dialysate from freely moving rats was carried out for mo

138 c oxide (NO) concentrations were measured in dialysate from healthy human skin, in vivo, both at rest

139 re important for the increase in dopamine in dialysate from NAcc and striatum during sexual behavior

140 Dopamine in dialysate from the nucleus accumbens (NAcc) increases du

141 ls of amino acid neurotransmitters in spinal dialysates from awake, unrestrained control and diabetic

142 Dopamine (DA) levels in dialysates from both areas, as the index of the activity

143 Dialysates from both the VTA and the NAC were collected

144 We found that the peptide concentration in dialysates from the hypothalamus was significantly highe

145 produce low millimolar levels of ethanol in dialysates from the NAcc; water intake was negligible.

146 or S-nitroso-N-acetylpenicillamine decreased dialysate GABA at a 500 microM concentration but increas

147 Formalin injection did not alter dialysate GABA concentrations in control rats, whereas i

148 200 microM L-NAME increased basal dialysate GABA, but to a lesser extent than the 100 micr

149 Veratridine caused a steep decrease in dialysate glucose after an initial delay of 7.5 min.

150 or the delay in the delay in the decrease in dialysate glucose.

151 esults in further and specific elevations in dialysate glutamate.

152 ascular event-free survival between flux and dialysate groups.

153 The fraction of SRFA in the dialysate had a different UV-visible absorption spectrum

154 Dialysate hippocampal purine levels increased during all

155 , P=0.12) and between ultrapure and standard dialysate (HR=0.90, 95% CI=0.61 to 1.32, P=0.60).

156 Dialysate IL-6 concentrations associate with variability

157 Cooled dialysate improved hemodynamic tolerability, and changes

158 ependent increase in GABA release in the CeA dialysate in both CET and naive rats.

159 F80B dialyzers, albumin was detected in the dialysate in four instances (total loss during dialysis,

160 r for creatinine analysis in real samples of dialysate in patients with renal failure.

161 culation does not limit solute exchange with dialysate in the cavity.

162 frame elevates ethanol concentration in NAcc dialysates in a manner consistent with the pattern of et

163 Dialysate insulin and glucose levels were unchanged or e

164 ynamic tolerability achieved by using cooled dialysate is effective at abrogating these effects.

165 ximal effect of addition of a sorbent to the dialysate is equivalent to that of an unlimited increase

166 tudy, it was reported that hemodialysis with dialysate [K+] (KD) of 1.0 or 2.0 mmol/L caused an incre

167 roM glutamate caused a transient increase in dialysate lactate concentration of 72 +/- 17%.

168 By measurement of changes in blood and dialysate levels of calcitriol, there was no evidence of

169 n injection significantly (P<0.05) increased dialysate levels of glutamate, aspartate, taurine, glyci

170 mM probenecid increased dose-dependently the dialysate levels of lactate, but without extracellular a

171 Basal dialysate levels of Met-enkephalin and Leu-enkephalin we

172 xposure to 70% N(2)O significantly increased dialysate levels of oxidation products of NO as well as

173 Striatal dialysate levels were analyzed for dopamine (DA), dihydr

174 ore potential interactions between serum and dialysate magnesium levels and risks associated with dia

175 nd patients with diabetes and that ultrapure dialysate may benefit patients with longer dialysis vint

176 ialysate bacterial contamination, simplified dialysate measurements, and proved to be a reliable meth

177 < 0.028), dialysate CML (39%; P < 0.03), and dialysate MG output (40%; P < 0.04).

178 obes were perfused at 0.3 microL/min and the dialysate mixed on-line with 6 mM naphthalene-2,3-dicarb

179 The dialysate monitor eliminated errors from dialysate bacte

180 tions in amygdalar FAAH activity and reduced dialysate N-arachidonoylethanolamine levels in the CeA.

181 ses in locomotor activity, body temperature, dialysate NE and plasma concentrations of ACTH and corti

182 ases in body temperature and the increase in dialysate NE, and markedly attenuated the increases in p

183 ommercial nicotine patch dose as measured by dialysate nicotine fluxes.

184 Moreover, the reduction in dialysate NO concentration was associated with a reducti

185 Changes in dialysate NO concentration, measured by electrochemical

186 he hypoglycemia-induced increments in muscle dialysate norepinephrine and epinephrine were similar, s

187 Dialysate norepinephrine concentration was significantly

188 nic volume expansion significantly increased dialysate norepinephrine concentration, while infusion o

189 Dialysate norepinephrine concentrations from these rats

190 centrations from these rats were compared to dialysate norepinephrine content from animals which rece

191 CIA was determined in dialysates obtained from wheat (2.12CI/mL and 3.78CI/mL

192 ncrease in lactate concentration in striatal dialysate of 58 +/- 10%.

193 d CCUG 46822), isolated in Pennsylvania from dialysate of a 77-year-old male with peritonitis.

194 Basal levels of dopamine in the dialysate of the caudate putamen were 4.2+/-0.2 nM in C5

195 dopamine and serotonin release into striatal dialysates of freely moving rats.

196 Prostaglandin E(2) (PGE(2)) was measured in dialysates of lumbar spinal cerebrospinal fluid concurre

197 The concentration of SeMet in the dialysates of the cereals, pulses and GLV ranged from 5.

198 The concentration of SeCys2 in the dialysates of the foods examined was negligible.

199 and cholecystokinin immunoreactive levels in dialysates of the posterior medial nucleus accumbens and

200 icotine SA, but not YA, reduced baseline VTA dialysate oleoylethanolamide (OEA) levels relative to ni

201 effects of high-flux dialysis and ultrapure dialysate on survival of hemodialysis patients are incom

202 s produced no change in VP levels, either in dialysate or plasma.

203 nditions were comprised of 2 L/hr/1.73 m2 of dialysate or prefiltered replacement fluid and hemofilte

204 Dialysate OT levels were 0.3+/-0.1, 2.8+/-1.2 and 1.3+/-

205 but without extracellular acidosis since the dialysate pH was not significantly reduced.

206 est that extreme concentrations of serum and dialysate potassium can trigger cardiac arrest.

207 alysis, and we review data linking serum and dialysate potassium concentrations with arrhythmias, car

208 the overall clinical scenario when choosing dialysate potassium concentrations, and an effective cha

209 e magnesium levels and risks associated with dialysate potassium levels.

210 he effects of both membrane permeability and dialysate purity on cardiovascular outcomes.

211 Peptides in dialysate rapidly degraded when stored at room temperatu

212 ensure that altered substance content in the dialysates reflects changes in release by the brain and

213 /mL and 3.78CI/mL for gastric and intestinal dialysate respectively) and rye breads (4.16CI/mL and 2.

214 /mL and 2.46CI/mL for gastric and intestinal dialysate respectively).

215 A standard addition study on dialysates revealed that while some peptides can be accu

216 or 6 weeks, baseline ACh levels in striatal dialysates rose from 73 fmol/min to 148 or 197 fmol/min

217 xidase to selectively remove D-serine from a dialysate sample.

218 N, extracellular 5-HT was 4 fmol/7.5 micro L dialysate sample.

219 Furthermore, typical dialysate samples (5-15 microL) suffer significant sensi

220 hs were temporally adjusted to correspond to dialysate samples and differentiated according to domina

221 The concentration of glutamate in dialysate samples collected immediately after paw formal

222 In a subsequent study, dialysate samples of norepinephrine were collected befor

223 Dialysate samples of norepinephrine were collected from

224 Dialysate samples were collected and SP-like immunoreact

225 Blood and dialysate samples were collected at the beginning, middl

226 Dialysate samples were collected before and after inject

227 intraperitoneal dosing, serum and peritoneal dialysate samples were obtained at set time intervals ov

228 d; in this group of rats video recording and dialysate samples were obtained when they were placed in

229 bited a reproducible, oscillating profile of dialysate serotonin concentration versus time.

230 ine, a serotonin uptake inhibitor, increased dialysate serotonin concentrations and stimulated releas

231 Dialysate serotonin concentrations change significantly

232 months of follow-up, relative to control, a dialysate sodium concentration of 135 mmol/L did not cha

233 To investigate whether lower dialysate sodium during hemodialysis reduces left ventri

234 Dialysate sodium of 135 mmol/L did not reduce left ventr

235 There is a global trend to lower dialysate sodium with the goal of reducing fluid overloa

236 lly recommended limits for this metal ion in dialysate solution.

237 A continuously flowing dialysate stream from a microdialysis probe was introduc

238 injection of sample from the hydrodynamic MD dialysate stream into a separation channel for analysis

239 ng serial injections, the device allowed the dialysate stream to be analyzed at 130-s intervals.

240 In addition, the elevation in dialysate taurine concentration was greater than that ob

241 Decreasing the dialysate temperature and increasing total dialysis time

242 circuit was -266+/-15 kJ per treatment, and dialysate temperature averaged 35.7+/-0.02 degrees C.

243 ircuit averaged 5+/-31 kJ per treatment, and dialysate temperature averaged 37.1+/-0.02 degrees C.

244 arding mitigation of hypotension by lowering dialysate temperature in patients with acute kidney inju

245 Studies have shown that lowering dialysate temperature in patients with end-stage renal d

246 intermittent renal replacement therapy with dialysate temperature of 35 degrees C or dialysate tempe

247 nts was twice as high during treatments with dialysate temperature of 37 degrees C, compared with tre

248 ith dialysate temperature of 35 degrees C or dialysate temperature of 37 degrees C.

249 n 6 months were randomized to dialyze with a dialysate temperature of either 37 degrees C or 0.5 degr

250 pilot study to evaluate the effect of lower dialysate temperature on hemodynamic status of criticall

251 Dialysate temperature was adjusted to either lower the c

252 uous dialysis under standard (36.5 degrees C dialysate temperature) conditions; we also scanned anoth

253 a blood temperature monitor with control of dialysate temperature.

254 Dialysate tested negative for galactomannan, demonstrati

255 -plasma ratio of creatinine (D/P Cr) and the dialysate TGF-beta1 concentration.

256 exhibited greater ET-1 addition to the renal dialysate than did control animals (681 +/- 91 versus 29

257 ialysis patients using icodextrin-containing dialysate that met all pharmacopoeia standards, a global

258 ect of addition of activated charcoal to the dialysate then was compared with the effect of increasin

259 aken at timed intervals and in ultrafiltrate/dialysate to determine serum concentration-time profiles

260 ients (control, 45; icodextrin, 47) with 4-h dialysate to plasma ratio creatinine >0.70 and D/D(0) gl

261 required the addition of phosphorus into the dialysate to prevent hypophosphatemia.

262 concentration correlated positively with the dialysate-to-plasma ratio of creatinine (D/P Cr) and the

263 stically significant correlation between the dialysate/ultrafiltrate samples and the corresponding va

264 Mean protein concentration for all 22 dialysate/ultrafiltrate samples was 4.2 +/- 4.0 mg/dL.

265 x dialyzers and either ultrapure or standard dialysate using a two-by-two factorial design.

266 Dialysate VEGF protein collected from the muscle interst

267 Dialysate VEGF-C concentration correlated positively wit

268 and UF targets, respectively; median drained dialysate volume was 16.2 L/24 h with 50% of patients us

269 The lactate concentration in striatal dialysate was assayed using an enzyme-based on-line assa

270 ggest that the decreased IL-6 content in the dialysate was caused principally by tissue alterations o

271 rough the blood compartment, and bicarbonate dialysate was circulated in the dialysate compartment.

272 Dialysate was collected and analysed for ATP ([ATP](d))

273 Dialysate was collected at baseline and during the ische

274 Dialysate was collected before, during, and following i.

275 Dialysate was collected for the duration of hemodialysis

276 From the continuous stream, the dialysate was injected into the separation capillary thr

277 Ethanol in the dialysate was measured by gas chromatography with flame

278 Total albumin loss into the dialysate was measured during each treatment.

279 Approximately 200 micro l of dialysate was recovered every 8-12 h, and the concentrat

280 Aqueous dialysate was segmented into nanoliter plugs by pumping

281 Dialysate was simultaneously collected for later analysi

282 n formalin-evoked SP-LI levels in spinal CSF dialysates was also determined.

283 Median recoveries of drug in dialysate were 9% (INH), 4% (RIF), 45% (PZA), and 2% (EM

284 2.6 nM), although levels in rat spinal cord dialysate were below the limit of detection.

285 d microbiological investigations of recalled dialysate were done.

286 Treatment sessions with cooler dialysate were more likely to reach prescribed ultrafilt

287 tions highly increased concentrations in the dialysate were observed in tape-stripped skin, whereas t

288 Dialysates were collected and analyzed by high-performan

289 Dialysates were collected every 20 min and dopamine cont

290 Dialysates were collected in different experiments eithe

291 The AHLs and AOHLs in dialysates were concentrated with solid-phase extraction

292 dial region of live crabs, and the resulting dialysates were desalted, concentrated, and analyzed by

293 and 3-methoxytyramine in rat brain striatal dialysates were determined before and after the injectio

294 Blank dialysates were negative for enzymatic activity that cou

295 nditions, glutamate concentrations in spinal dialysates were significantly (P<0.05) decreased in diab

296 e is integrated with a PDMS chip that merges dialysate with fluorogenic reagent and segments the flow

297 cotine fluxes through the skin barriers into dialysate with high temporal resolution.

298 t the study, albumin was undetectable in the dialysate with T220L dialyzers.

299 , during and after TENS and analyzed GABA in dialysates with high performance liquid chromatography.

300 cuit using a calcium-free citrate-containing dialysate, with calcium reinjected according to ionic di